![Debra A. Odink](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Debra A. Odink
President chez
Thryv Therapeutics, Inc.
Profil
Debra A. Odink currently works at Thryv Therapeutics, Inc., as President & Chief Development Officer from 2022.
Dr. Odink also formerly worked at Elan Pharmaceuticals LLC, as Associate Director-Technical Affairs, Peninsula Pharmaceuticals, Inc., as VP-Pharmaceutical Chemistry & Product Development in 2005, Anthera Pharmaceuticals, Inc., as Chief Technology Officer & Senior Vice President from 2011 to 2016, Hoffmann-La Roche, Inc., as Principal, SiteOne Therapeutics, Inc., as Chief Development Officer, and Eiger BioPharmaceuticals, Inc., as Senior Vice President-Technical Operations.
Dr. Odink received her undergraduate degree from California State University-Stanislaus and doctorate degree from the University of California, Davis.
Postes actifs de Debra A. Odink
| Sociétés | Poste | Début |
|---|---|---|
Thryv Therapeutics, Inc.
 Thryv Therapeutics, Inc. Medical/Nursing ServicesHealth Services Develops therapies for the treatment of long qt Syndrome | President | 01/09/2022 |
Anciens postes connus de Debra A. Odink
| Sociétés | Poste | Fin |
|---|---|---|
| ANTHERA PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 05/01/2016 |
Peninsula Pharmaceuticals, Inc.
 Peninsula Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and commercializes antibiotics to treat life-threatening infections | Corporate Officer/Principal | 01/07/2005 |
SiteOne Therapeutics, Inc.
 SiteOne Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops pain therapeutics for peripheral nervous system | Corporate Officer/Principal | - |
| EIGER BIOPHARMACEUTICALS | Corporate Officer/Principal | - |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Corporate Officer/Principal | - |
Formation de Debra A. Odink
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
42
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Peninsula Pharmaceuticals, Inc.
Peninsula Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and commercializes antibiotics to treat life-threatening infections | Commercial Services |
Anthera Pharmaceuticals, Inc.
 Anthera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of medicines for patients with unmet medical needs | Health Technology |
Elan Pharmaceuticals LLC
 Elan Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Health Technology |
California State University-Stanislaus
 California State University-Stanislaus Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Davis
 University of California, Davis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SiteOne Therapeutics, Inc.
SiteOne Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops pain therapeutics for peripheral nervous system | Health Technology |
Eiger BioPharmaceuticals, Inc.
 Eiger BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat and cure hepatitis delta virus and other serious diseases | Health Technology |
Thryv Therapeutics, Inc.
Thryv Therapeutics, Inc. Medical/Nursing ServicesHealth Services Develops therapies for the treatment of long qt Syndrome | Health Services |
